Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
11/30/2021
11/30/2020
11/30/2012
11/30/2011
11/30/2010
Revenue
0
0
0
0
0
0
Revenue Growth (YoY)
--
--
--
--
--
--
Cost of Revenue
0
0
1
0
0
0
Gross Profit
0
0
0
0
0
0
Selling, General & Admin
0
0
0
0
0
0
Research & Development
--
--
--
--
--
--
Operating Expenses
0
0
0
0
0
0
Other Non Operating Income (Expenses)
--
--
--
--
--
--
Pretax Income
0
0
-1
0
0
1
Income Tax Expense
0
0
0
0
0
0
Net Income
0
0
-1
0
0
1
Net Income Growth
--
-100%
--
--
-100%
--
Shares Outstanding (Diluted)
0.11
54.87
51.77
0.22
0.11
0.07
Shares Change (YoY)
--
6%
--
100%
56.99%
--
EPS (Diluted)
-2.68
0
-0.02
-0.9
-2.63
24.57
EPS Growth
--
-66%
--
-66%
-111%
--
Free Cash Flow
0
0
-1
0
0
1
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
0%
0%
0%
0%
0%
0%
Operating Margin
0%
0%
0%
0%
0%
0%
Profit Margin
0%
0%
0%
0%
0%
0%
Free Cash Flow Margin
0%
0%
0%
0%
0%
0%
EBITDA
0
--
--
0
0
0
EBITDA Margin
0%
--
--
0%
0%
0%
D&A For EBITDA
0
--
--
0
0
0
EBIT
0
0
-1
0
0
0
EBIT Margin
0%
0%
0%
0%
0%
0%
Effective Tax Rate
0%
0%
0%
0%
0%
0%
Follow-Up Questions
What are SH Resources and Development Corp's key financial statements?
According to the latest financial statement (Form-10K), Biolife Sciences Inc has a total asset of $0, Net loss of $0
What are the key financial ratios for SDAD?
Biolife Sciences Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is SH Resources and Development Corp's revenue broken down by segment or geography?
Biolife Sciences Inc largest revenue segment is Drug Discovery, at a revenue of 31,313,392,000 in the most earnings release.For geography, Europe is the primary market for Biolife Sciences Inc, at a revenue of 29,377,364,000.
Is SH Resources and Development Corp profitable?
no, according to the latest financial statements, Biolife Sciences Inc has a net loss of $0
Does SH Resources and Development Corp have any liabilities?
yes, Biolife Sciences Inc has liability of 1
How many outstanding shares for SH Resources and Development Corp?
Biolife Sciences Inc has a total outstanding shares of 57.13